SEBI Reg. Investment Advisor

Download App

MoneyWorks4Me

Mastek surges on partnering with Onyx Health to accelerate healthcare data interoperability

28 Aug 2024 Evaluate

Mastek is currently trading at Rs. 3025.40, up by 27.10 points or 0.90% from its previous closing of Rs. 2998.30 on the BSE.

The scrip opened at Rs. 2987.50 and has touched a high and low of Rs. 3083.35 and Rs. 2970.00 respectively. So far 4843 shares were traded on the counter.

The BSE group 'A' stock of face value Rs. 5 has touched a 52 week high of Rs. 3147.00 on 16-Feb-2024 and a 52 week low of Rs. 2105.95 on 26-Oct-2023.

Last one week high and low of the scrip stood at Rs. 3083.35 and Rs. 2927.15 respectively. The current market cap of the company is Rs. 9348.02 crore.

The promoters holding in the company stood at 36.25%, while Institutions and Non-Institutions held 21.15% and 42.60% respectively.

Mastek has entered into a strategic partnership with Onyx Health, an innovator in healthcare interoperability solutions. This collaboration aims to expedite the adoption of FHIR (Fast Healthcare Interoperability Resources) standards, driving enhanced data interoperability and ultimately better health outcomes for patients.

In an era where seamless data exchange is critical for effective healthcare delivery, the partnership between Mastek and Onyx Health will provide health plans with an out-of-the-box compliance solution for CMS-9115 (Patient Access API) and CMS-0057 (Advancing Interoperability and Electronic Prior Auth) rules. These regulations, pivotal to modernizing healthcare data exchange, require health plans to ensure secure, standardized data sharing across systems. Mastek and Onyx Health are at the forefront of delivering comprehensive solutions to meet these stringent regulatory requirements efficiently and effectively.

This strategic partnership represents a significant step forward in addressing the interoperability challenges faced by the healthcare industry. By combining the strengths of Mastek and Onyx Health, this collaboration promises to deliver innovative solutions that will shape the future of healthcare data exchange.

Mastek together with its subsidiaries, provides enterprise technology solutions and platforms for insurance, government, and financial services organizations worldwide.


Mastek Share Price

1715.60 -35.05 (-2.00%)
24-Apr-2026 09:45 View Price Chart
Peers
Company Name CMP
TCS 2470.95
Infosys 1196.95
HCL Tech. 1229.15
Wipro 200.15
Tech Mahindra 1390.10
View more..

About MoneyWorks4Me

MoneyWorks4Me is a SEBI-registered Investment Adviser (IA) dedicated to helping investors build long-term wealth through transparent, research-driven, conflict-free guidance. Founded in 2008, we started our journey as a Research Analyst (RA), providing deep fundamental analysis, intrinsic value insights, and long-term investing frameworks for Indian equities. In 2017, we transitioned to a full-fledged SEBI-registered Investment Adviser, strengthening our commitment to acting as a fiduciary—always putting the investor’s interest first.

Our Vision

To become India’s most trusted, research-powered fiduciary advisory platform—where every investor, regardless of experience, can make calm, confident, and well-reasoned investment decisions.

What Makes MoneyWorks4Me Different

Our Approach: Ensuring compounding work its magic on client portfolio.

MoneyWorks4Me ensures this through:

×